retatrutide triple agonist gip glp-1 glucagon phase 3 2025 Michael Weintraub, MD on X: "Retatrutide, a (GLP1, GIP, glucagon), just released 2 trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight ๐จ Today, retatrutide, the GIP/GLP-1/glucagon
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 27 - Nov 1










:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)

















